SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-118162
Filing Date
2013-03-21
Accepted
2013-03-21 07:02:22
Documents
7
Period of Report
2013-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d504317d8k.htm 8-K 16155
2 EX-99.1 d504317dex991.htm EX-99.1 90363
3 EX-99.2 d504317dex992.htm EX-99.2 104228
4 GRAPHIC g504317bar.jpg GRAPHIC 444
5 GRAPHIC g504317logo.jpg GRAPHIC 7427
6 GRAPHIC g504317side1.jpg GRAPHIC 27905
7 GRAPHIC g504317side2.jpg GRAPHIC 34221
  Complete submission text file 0001193125-13-118162.txt   308981
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15313 | Film No.: 13706379
SIC: 2833 Medicinal Chemicals & Botanical Products